SCHEMBL3846561

SCHEMBL3846561

C=COC(=O)c1cccc(S(N)(=O)=O)c1[C@@H]1CC2C3CCc4ccccc4C3CC[C@]2(C)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 13/20 0.39
CYP3A4 P08684 1/20 0.36
CA2 P00918 4/20 0.36
CA1 P00915 3/20 0.36
CA9 Q16790 3/20 0.36
ESR1 P03372 3/20 0.36
LMNA P02545 1/20 0.36
NR3C1 P04150 1/20 0.36
SHBG P04278 1/20 0.36
FYN P06241 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADRA2C P18825 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
HTR2B P41595 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA4 P22748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845915 0.86 AKR1C3 (0.39) STSCYP3A4ESR1LMNANR3C1
SCHEMBL8518161 0.68 SHBG (0.48) STSCYP3A4ESR1LMNANR3C1
SCHEMBL9255609 0.68 SHBG (0.43) STSCYP3A4ESR1LMNANR3C1
SCHEMBL5682603 0.68 SHBG (0.48) STSCYP3A4ESR1LMNANR3C1
SCHEMBL5682532 0.68 SHBG (0.48) STSCYP3A4ESR1LMNANR3C1
SCHEMBL3845729 0.67 SOD1 (0.33) STSCA2CA1CA9ESR1
Sulfamate SCHEMBL2451788 0.66 STS (0.65) STSCA2CA1CA9ESR1
SCHEMBL3868623 0.65 CA2 (0.67) STSCYP3A4CA2CA1CA9
SCHEMBL5975384 0.62 ESR1 (0.61) STSCYP3A4ESR1ESR2AKR1C3
SCHEMBL1898745 0.62 CYP2C9 (0.37) CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039702-A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-25 EP disclosed